S

SOTAC PHARMACEUTICALS LTD

SOTACNSE
Market snapshot · 2026-08-11 11:13 UTC

94.90

+₹2.95 (+3.21%)

MARKET CAP

STOCK P/E

52W HIGH

₹94.90

52W LOW

₹86.00

BOOK VALUE

EPS

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

3,600

P/B RATIO

PEG RATIO

Sector

Healthcare

Themes

Healthcare
₹95.90₹95.65₹95.40₹95.15₹94.90VolumeJul '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

Sector: Healthcare

Healthcare Peers8 peers
Avg P/E: 24.6x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
7.3x
Undervalued
-70% vs avg
15.4x
Undervalued
-37% vs avg
68.6x
Premium
+179% vs avg
SUNREST.NS,0P0001RTOB,0
SUNRESTHealthcare
6.9x
Undervalued
-72% vs avg
KRMAYURVED
KRMAYURVEDHealthcare
MEDISTEP
MEDISTEPHealthcare
CURIS
CURISHealthcare
WHY THESE PEERS

Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹18 CrSep 2024

Latest net profit

₹0.87 CrSep 2024

Net margin

5.2%Sep 2024

Net Profit

₹0.87 CrProfit conversion

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q2 '24Q3 '24Q4 '24Q1 '25Q2 '250.0%4.0%8.0%12.0%16.0%0.00 Cr5.00 Cr10 Cr15 Cr20 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q2 '24Q3 '24Q4 '24Q1 '25Q2 '250.00 Cr5.00 Cr10 Cr15 Cr20 Cr₹0₹0₹1₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr5.00 Cr10 Cr15 Cr20 Cr

Latest reported period: Sep 2024

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Sales18.9114.217.6816.3113.0117.6
Expenses16.6511.514.751410.9116.08
Operating Profit1.82.062.241.581.50.92
OPM %9.52%14.51%12.67%9.69%11.53%5.23%
Other Income0.230.290.270.530.430.49
Interest0.340.20.230.250.260.24
Depreciation0.460.640.690.730.60.6
Profit before tax1.692.152.281.861.671.17
Tax %28.4%22.33%26.32%25.81%25.15%25.64%
Net Profit1.211.671.681.381.250.87
EPS in Rs1.121.251.13

All values in Rs. Crore unless otherwise stated. Source: CMIE Prowess, Quarterly Interim Standalone.

Shareholding Pattern

HolderMar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Promoters72.85%72.85%72.85%72.85%72.85%
FII8.99%8.88%15.12%16.14%16.79%
DII0.68%
Public5.82%6.01%4.70%5.12%6.52%
Others12.34%12.26%6.65%5.89%3.84%
Mar 2026
Promoters
FII
Public
Others